Interestingly, PCSK9 inhibition is being explored as a new cancer therapy to increase the response of tumors to checkpoint therapies, which might be also applied to the treatment of aggressive ECs overexpressing PSCK9 [61, 62]. Here, PCSK9 is linked to cancer.